Ikarian Capital, LLC Kura Oncology, Inc. Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$20.85 - $29.88 $325,322 - $466,217	-15,603 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$24.75 - $39.14 $108,900 - $172,216	4,400 Added 39.28%	15,603 $441,000
Q4 2020 Feb 12, 2021	BUY	$29.0 - $41.62 $145,000 - $208,100	5,000 Added 80.61%	11,203 $366,000
Q3 2020 Nov 16, 2020	SELL	$16.3 - $30.64 $7.49 Million - $14.1 Million	-459,416 Reduced 98.67%	6,203 $189,000
Q2 2020 Aug 14, 2020	SELL	$7.95 - $18.81 $2.34 Million - $5.53 Million	-294,184 Reduced 38.72%	465,619 $7.59 Million
Q1 2020 May 15, 2020	BUY	$6.45 - $14.04 $4.9 Million - $10.7 Million	759,803 New	759,803 $7.56 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.